Direxion Daily S&P Biotech Bear 3X ETF

VS TR 2x Long VIX Futures ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra VIX Short-Term Futures

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bear 3X ETF

Direxion Daily 20+ Yr Trsy Bear 3X ETF

Direxion Technology Bear 3X Shares

MicroSectors Gold Miners 3X Leveraged ETN

ProShares UltraPro Short S&P500

Direxion Daily S&P Biotech Bull 3X ETF

Bank Of Montreal MAX S&P 500 4X Leveraged ETNs due October 30

Direxion Daily Small Cap Bull 3X ETF

GraniteShares 1.5x Long META Daily ETF

ProShares UltraPro Dow30

Direxion Daily 20+ Yr Trsy Bull 3X ETF

Altimmune Inc. Common Stock

Direxion Daily Semicondct Bull 3X ETF

Direxion Daily Technology Bull 3X ETF

Direxion Daily Financial Bull 3X ETF

Edible Garden AG Incorporated Common Stock

D-Wave Quantum Inc. Common Shares

Ascentage Pharma Group International American Depository Shares

Trio Petroleum Corp. Common Stock

XPeng Inc. American depositary shares each representing two Class A ordinary shares

AgEagle Aerial Systems Inc. Common Stock

Dycom Industries Inc. Common Stock

Protagenic Therapeutics Inc. Common Stock

Quad Graphics Inc Class A Common Stock

LQR House Inc. Common Stock

Siyata Mobile Inc. Common Shares

Neuraxis Inc. Common Stock

Carter's Inc. Common Stock

NWTN Inc. Class B Ordinary Shares

UnitedHealth Group Incorporated Common Stock (DE)

Aytu BioPharma Inc.  Common Stock

AST SpaceMobile Inc. Class A Common Stock

Nuvve Holding Corp. Common Stock

IBO (Listing Market - NYSE Amex Network B F)

Take-Two Interactive Software Inc. Common Stock

Click here to get full coverage on Lacklustre Performance Is Driving Immatics N.V.'s (NASDAQ:IMTX) Low P/S - simplywall.st

Lacklustre Performance Is Driving Immatics N.V.'s (NASDAQ:IMTX) Low P/S  simplywall.st

Lacklustre Performance Is Driving Immatics N.V.'s (NASDAQ:IMTX) Low P/S - simplywall.st

Click here to get full coverage on (IMTX) Trading Advice - news.stocktradersdaily.com

(IMTX) Trading Advice  news.stocktradersdaily.com

(IMTX) Trading Advice - news.stocktradersdaily.com

Click here to get full coverage on We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely - Yahoo Finance

We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely  Yahoo Finance

We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely - Yahoo Finance

Click here to get full coverage on Immatics Announces First Quarter 2025 Financial Results and Business Update - Stock Titan

Immatics Announces First Quarter 2025 Financial Results and Business Update  Stock Titan

Immatics Announces First Quarter 2025 Financial Results and Business Update - Stock Titan

Click here to get full coverage on Immatics (IMTX) Gets a Buy from Bank of America Securities - The Globe and Mail

Immatics (IMTX) Gets a Buy from Bank of America Securities  The Globe and Mail

Immatics (IMTX) Gets a Buy from Bank of America Securities - The Globe and Mail

Click here to get full coverage on IMMATICS N.V Earnings Preview: Recent $IMTX Insider Trading, Hedge Fund Activity, and More - Nasdaq

IMMATICS N.V Earnings Preview: Recent $IMTX Insider Trading, Hedge Fund Activity, and More  Nasdaq

IMMATICS N.V Earnings Preview: Recent $IMTX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Click here to get full coverage on Immatics Announces Full Year 2024 Financial Results and Business Update - GlobeNewswire

Immatics Announces Full Year 2024 Financial Results and Business Update  GlobeNewswire

Immatics Announces Full Year 2024 Financial Results and Business Update - GlobeNewswire

Click here to get full coverage on Immatics: Q1 Earnings Snapshot - San Antonio Express-News

Immatics: Q1 Earnings Snapshot  San Antonio Express-News

Immatics: Q1 Earnings Snapshot - San Antonio Express-News

Click here to get full coverage on Immatics N.V.: Trading Below Cash, But Not Without Reason (NASDAQ:IMTX) - Seeking Alpha

Immatics N.V.: Trading Below Cash, But Not Without Reason (NASDAQ:IMTX)  Seeking Alpha

Immatics N.V.: Trading Below Cash, But Not Without Reason (NASDAQ:IMTX) - Seeking Alpha

Click here to get full coverage on IMTX Sees Revenue Decline, Highlights Advances in Melanoma Thera - GuruFocus

IMTX Sees Revenue Decline, Highlights Advances in Melanoma Thera  GuruFocus

IMTX Sees Revenue Decline, Highlights Advances in Melanoma Thera - GuruFocus

Click here to get full coverage on Immatics: Q1 Earnings Snapshot - The Washington Post

Immatics: Q1 Earnings Snapshot  The Washington Post

Immatics: Q1 Earnings Snapshot - The Washington Post

Click here to get full coverage on Investors in Immatics (NASDAQ:IMTX) have unfortunately lost 53% over the last year - Yahoo Finance

Investors in Immatics (NASDAQ:IMTX) have unfortunately lost 53% over the last year  Yahoo Finance

Investors in Immatics (NASDAQ:IMTX) have unfortunately lost 53% over the last year - Yahoo Finance

Click here to get full coverage on Is Immatics (IMTX) the Best German Stock to Buy According to Hedge Funds? - Insider Monkey

Is Immatics (IMTX) the Best German Stock to Buy According to Hedge Funds?  Insider Monkey

Is Immatics (IMTX) the Best German Stock to Buy According to Hedge Funds? - Insider Monkey

Click here to get full coverage on (IMTX) Proactive Strategies - news.stocktradersdaily.com

(IMTX) Proactive Strategies  news.stocktradersdaily.com

(IMTX) Proactive Strategies - news.stocktradersdaily.com

Click here to get full coverage on Breakthrough Melanoma Treatment IMA203 : Phase 1b Results and Phase 3 Progress Coming to ASCO 2025 - Stock Titan

Breakthrough Melanoma Treatment IMA203 : Phase 1b Results and Phase 3 Progress Coming to ASCO 2025  Stock Titan

Breakthrough Melanoma Treatment IMA203 : Phase 1b Results and Phase 3 Progress Coming to ASCO 2025 - Stock Titan

Click here to get full coverage on Is Immatics (NASDAQ:IMTX) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Is Immatics (NASDAQ:IMTX) the Best Biotech Penny Stock to Buy According to Hedge Funds?  Yahoo Finance

Is Immatics (NASDAQ:IMTX) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Click here to get full coverage on Immatics: A Promising TCR Pipeline (NASDAQ:IMTX) - Seeking Alpha

Immatics: A Promising TCR Pipeline (NASDAQ:IMTX)  Seeking Alpha

Immatics: A Promising TCR Pipeline (NASDAQ:IMTX) - Seeking Alpha

Click here to get full coverage on IMTX: 3 Small-Cap Healthcare Stocks With Big Upside Potential - StockNews

IMTX: 3 Small-Cap Healthcare Stocks With Big Upside Potential  StockNews

IMTX: 3 Small-Cap Healthcare Stocks With Big Upside Potential - StockNews

Click here to get full coverage on Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME - GlobeNewswire

Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME  GlobeNewswire

Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME - GlobeNewswire

Click here to get full coverage on Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs - TipRanks

Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs  TipRanks

Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs - TipRanks

Click here to get full coverage on Immatics Announces Proposed $150 Million Public Offering - GlobeNewswire

Immatics Announces Proposed $150 Million Public Offering  GlobeNewswire

Immatics Announces Proposed $150 Million Public Offering - GlobeNewswire

Click here to get full coverage on Immatics Advances Cancer Immunotherapy with Phase 3 Trial and Strong Financials - TipRanks

Immatics Advances Cancer Immunotherapy with Phase 3 Trial and Strong Financials  TipRanks

Immatics Advances Cancer Immunotherapy with Phase 3 Trial and Strong Financials - TipRanks

Click here to get full coverage on Immatics NV earnings missed by €0.07, revenue topped estimates - Investing.com

Immatics NV earnings missed by €0.07, revenue topped estimates  Investing.com

Immatics NV earnings missed by €0.07, revenue topped estimates - Investing.com

Click here to get full coverage on Immatics Announces First Quarter 2025 Financial Results and Business Update - TradingView

Immatics Announces First Quarter 2025 Financial Results and Business Update  TradingView

Immatics Announces First Quarter 2025 Financial Results and Business Update - TradingView

Click here to get full coverage on 13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey

13 Best Biotech Penny Stocks to Buy According to Hedge Funds  Insider Monkey

13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey

Click here to get full coverage on Immatics NV reports results for the quarter ended December 31 - Earnings Summary - TradingView

Immatics NV reports results for the quarter ended December 31 - Earnings Summary  TradingView

Immatics NV reports results for the quarter ended December 31 - Earnings Summary - TradingView

Click here to get full coverage on Immatics NV earnings missed by €0.07, revenue topped estimates - Investing.com South Africa

Immatics NV earnings missed by €0.07, revenue topped estimates  Investing.com South Africa

Immatics NV earnings missed by €0.07, revenue topped estimates - Investing.com South Africa

Click here to get full coverage on IMTX Stock Price and Chart — NASDAQ:IMTX - TradingView

IMTX Stock Price and Chart — NASDAQ:IMTX  TradingView

IMTX Stock Price and Chart — NASDAQ:IMTX - TradingView

Click here to get full coverage on Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics - GlobeNewswire

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics  GlobeNewswire

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics - GlobeNewswire

Click here to get full coverage on Mizuho Initiates Coverage of Immatics (IMTX) with Buy Recommendation - Nasdaq

Mizuho Initiates Coverage of Immatics (IMTX) with Buy Recommendation  Nasdaq

Mizuho Initiates Coverage of Immatics (IMTX) with Buy Recommendation - Nasdaq

Click here to get full coverage on Immatics Announces Completion of Business Combination and Listing on NASDAQ - GlobeNewswire

Immatics Announces Completion of Business Combination and Listing on NASDAQ  GlobeNewswire

Immatics Announces Completion of Business Combination and Listing on NASDAQ - GlobeNewswire

Click here to get full coverage on Immatics (IMTX) Stock Price, News & Analysis - MarketBeat

Immatics (IMTX) Stock Price, News & Analysis  MarketBeat

Immatics (IMTX) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Immatics Biotechnologies completes blank-check deal with Arya Sciences Acquisition Corp., begins trading - The Business Journals

Immatics Biotechnologies completes blank-check deal with Arya Sciences Acquisition Corp., begins trading  The Business Journals

Immatics Biotechnologies completes blank-check deal with Arya Sciences Acquisition Corp., begins trading - The Business Journals

Click here to get full coverage on Fundus biomicroscopy: Complete remission of the retinallesions was... - ResearchGate

Fundus biomicroscopy: Complete remission of the retinallesions was...  ResearchGate

Fundus biomicroscopy: Complete remission of the retinallesions was... - ResearchGate

Click here to get full coverage on The Manufacturers Life Insurance Company Sells 71,487 Shares of Immatics (NASDAQ:IMTX) - Defense World

The Manufacturers Life Insurance Company Sells 71,487 Shares of Immatics (NASDAQ:IMTX)  Defense World

The Manufacturers Life Insurance Company Sells 71,487 Shares of Immatics (NASDAQ:IMTX) - Defense World

Click here to get full coverage on Immatics (IMTX) Projected to Post Quarterly Earnings on Tuesday - Defense World

Immatics (IMTX) Projected to Post Quarterly Earnings on Tuesday  Defense World

Immatics (IMTX) Projected to Post Quarterly Earnings on Tuesday - Defense World

Click here to get full coverage on Guggenheim Capital LLC Takes $101,000 Position in Immatics (NASDAQ:IMTX) - Defense World

Guggenheim Capital LLC Takes $101,000 Position in Immatics (NASDAQ:IMTX)  Defense World

Guggenheim Capital LLC Takes $101,000 Position in Immatics (NASDAQ:IMTX) - Defense World

Click here to get full coverage on Immatics FY2025 EPS Forecast Increased by Cantor Fitzgerald - Defense World

Immatics FY2025 EPS Forecast Increased by Cantor Fitzgerald  Defense World

Immatics FY2025 EPS Forecast Increased by Cantor Fitzgerald - Defense World

POST

Immatics N.V. Ordinary Shares

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as TCR-engineered autologous or allogeneic adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.

Immatics NV (IMTX)

Price Chart

Key Statistics

Technicals

About IMTX

Latest News

Lacklustre Performance Is Driving Immatics N.V.'s (NASDAQ:IMTX) Low P/S - simplywall.st

(IMTX) Trading Advice - news.stocktradersdaily.com

We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers